XML 44 R30.htm IDEA: XBRL DOCUMENT v3.20.2
CHANGE IN CONTROL AND REVERSE RECAPITALIZATION TRANSACTIONS (Details) - USD ($)
Jul. 31, 2020
Apr. 13, 2020
Feb. 10, 2020
Preferred stock $ 202    
Common stock 9,669    
Additional paid-in capital 1,456,644    
Adjustment to stockholders' equity (deficiency) (150,341)  
Series B Preferred Stock      
Preferred stock $ 72    
Bio-Matrix Scientific Group, Inc      
Cash   $ 572  
Investment securities   8,797  
Total current assets   9,369  
Preferred stock   202  
Common stock   781  
Additional paid-in capital   8,314  
Adjustment to stockholders' equity (deficiency)   9,369  
Bio-Matrix Scientific Group, Inc | Series B Preferred Stock      
Preferred stock   $ 72